Home > products > custom-nanocomposites
> nanopeptides
> fluvoxamine-lnp-tfr-sequence-thrppmwspvwp-100nm
Fluvoxamine@LNP-TFR (sequence:THRPPMWSPVWP) 100nm
Fluvoxamine@LNP-peptide TFR (sequence:THRPPMWSPVWP)
Product description
The Fluvoxamine@Liposome nanoparticles-TFR (sequence: THRPPMWSPVWP) involves the targeted delivery of the therapeutic drug fluvoxamine using liposome nanoparticles functionalized with a peptide sequence that targets transferrin receptors. This type of drug delivery system has the potential to enhance the specificity and efficiency of drug delivery to particular cells or tissues in the body.
Appearance | N/A |
---|---|
Molecular weight | N/A |
Solubility | N/A |
Synonym | Fluvoxamine@LNP-peptide TFR (sequence:THRPPMWSPVWP) |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 3 weeks |
Stability | 6 months |
Document
Related Product